The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, pharmacology, and preliminary clinical activity of MM-151: An oligocolnal anti-EGFR theraputic in patients with cetuximab-resistant CRC and other refractory solid tumors.
 
Christopher Hanyoung Lieu
Consulting or Advisory Role - Sanofi
 
Muralidhar Beeram
Honoraria - Genentech/Roche
Consulting or Advisory Role - Lilly (I); MethylGene (I); Symphony Evolution (I); Vaccinex (I)
Speakers' Bureau - Genentech
 
Wael A. Harb
No Relationships to Disclose
 
Jeffrey D. Kearns
Employment - Merrimack
Patents, Royalties, Other Intellectual Property - Merrimack (Inst)
 
Callum Mortimer Sloss
Employment - Merrimack
 
Rachel Nering
Employment - Merrimack
 
Alex A. Adjei
No Relationships to Disclose
 
Beni B. Wolf
Employment - Merrimack
Research Funding - Merrimack
Patents, Royalties, Other Intellectual Property - Merrimack (Inst)